Aralez Pharma (ARLZ) Slammed, Halted Ahead of PDUFA Date

September 14, 2016 11:40 AM EDT
Get Alerts ARLZ Hot Sheet
Trade ARLZ Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Aralez Pharma (NASDAQ: ARLZ) has resumed trading and is down 14%. Today is the company's PDUFA date for YOSPRALA.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk, Trading Halts

Related Entities


Add Your Comment